THE ROLE OF REPETITIVE DNA-SEQUENCES IN THE SIZE VARIATION OF EPSTEIN-BARR-VIRUS (EBV) NUCLEAR ANTIGENS, AND THE IDENTIFICATION OF DIFFERENT EBV ISOLATES USING RFLP AND PCR ANALYSIS

被引:57
作者
FALK, K
GRATAMA, JW
ROWE, M
ZOU, JZ
KHANIM, F
YOUNG, LS
OOSTERVEER, MAP
ERNBERG, I
机构
[1] DR DANIEL DEN HOED CANC CTR,DEPT CLIN & TUMORIMMUNOL,ROTTERDAM,NETHERLANDS
[2] CRC LABS,DEPT CANC STUDIES,BIRMINGHAM,W MIDLANDS,ENGLAND
基金
英国惠康基金;
关键词
D O I
10.1099/0022-1317-76-4-779
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The six Epstein-Barr virus (EBV) nuclear antigen proteins (EBNA-1-6) show characteristic size variations between different virus isolates; this is a feature that has been used to identify the source of virus isolates in epidemiological studies (Ebnotyping). We have now studied the correlation between restriction fragment length polymorphisms (RFLPs) within exons coding for the EBNAs and the molecular masses of the respective proteins. The B95-8 EBV strain was used as the prototype virus. The variation in apparent molecular mass of EBNA-1, -3 and -6 correlated positively with the size of RFLP coding for repeat sequences in these polypeptides. For EBNA-2, no correlation between apparent molecular mass and length of the repetitive sequences was found. The EBNA-4 protein showed virtually no variation in apparent molecular mass and RFLP size across the repeat sequence. Based on the strong correlation between apparent molecular mass and RFLP size for EBNA-6, we developed an EBNA-6 PCR assay that discriminated between different isolates of EBV. This assay offers the advantage of EBV characterization using uncultured material (e.g. throat washings, blood or biopsies), thus avoiding the selection against poorly transforming strains that occurs during establishment of lymphoblastoid cell lines required for Ebnotyping at the protein level.
引用
收藏
页码:779 / 790
页数:12
相关论文
共 42 条
[1]   A PUTATIVE TRANSFORMING GENE OF JIJOYE VIRUS DIFFERS FROM THAT OF EPSTEIN-BARR VIRUS PROTOTYPES [J].
ADLDINGER, HK ;
DELIUS, H ;
FREESE, UK ;
CLARKE, J ;
BORNKAMM, GW .
VIROLOGY, 1985, 141 (02) :221-234
[2]   SIMPLE, SENSITIVE, AND SPECIFIC DETECTION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IN CLINICAL SPECIMENS BY POLYMERASE CHAIN-REACTION WITH NESTED PRIMERS [J].
ALBERT, J ;
FENYO, EM .
JOURNAL OF CLINICAL MICROBIOLOGY, 1990, 28 (07) :1560-1564
[3]   HLA-A11 EPITOPE LOSS ISOLATES OF EPSTEIN-BARR-VIRUS FROM A HIGHLY A11+ POPULATION [J].
DECAMPOSLIMA, PO ;
GAVIOLI, R ;
ZHANG, QJ ;
WALLACE, LE ;
DOLCETTI, R ;
ROWE, M ;
RICKINSON, AB ;
MASUCCI, MG .
SCIENCE, 1993, 260 (5104) :98-100
[4]   THE EPSTEIN-BARR VIRUS PROTEINS [J].
DILLNER, J ;
KALLIN, B .
ADVANCES IN CANCER RESEARCH, 1988, 50 :95-158
[5]   LYMPHOBLASTOID CELL-LINES AND BURKITTS-LYMPHOMA-DERIVED CELL-LINES DIFFER IN THE EXPRESSION OF A 2ND EPSTEIN-BARR-VIRUS ENCODED NUCLEAR ANTIGEN [J].
ERNBERG, I ;
KALLIN, B ;
DILLNER, J ;
FALK, K ;
EHLINHENRIKSSON, B ;
HAMMARSKJOLD, ML ;
KLEIN, G .
INTERNATIONAL JOURNAL OF CANCER, 1986, 38 (05) :729-737
[6]   ACYCLOVIR EFFICIENTLY INHIBITS OROPHARYNGEAL EXCRETION OF EPSTEIN-BARR-VIRUS IN PATIENTS WITH ACUTE INFECTIOUS-MONONUCLEOSIS [J].
ERNBERG, I ;
ANDERSSON, J .
JOURNAL OF GENERAL VIROLOGY, 1986, 67 :2267-2272
[7]  
ERNBERG I, 1989, EPSTEIN BARR VIRUS H, P341
[8]   AN ORIGIN OF DNA-REPLICATION (ORIP) IN HIGHLY METHYLATED EPISOMAL EPSTEIN-BARR-VIRUS DNA LOCALIZES TO A 4.5-KB UNMETHYLATED REGION [J].
FALK, K ;
ERNBERG, I .
VIROLOGY, 1993, 195 (02) :608-615
[9]   A TECHNIQUE FOR RADIOLABELING DNA RESTRICTION ENDONUCLEASE FRAGMENTS TO HIGH SPECIFIC ACTIVITY [J].
FEINBERG, AP ;
VOGELSTEIN, B .
ANALYTICAL BIOCHEMISTRY, 1983, 132 (01) :6-13
[10]  
FRIIS AMC, 1995, IN PRESS J MED VIROL